Moderna became the latest company to announce that it would apply for authorization of emergency use of its coronavirus vaccine candidate.
In a statement on plans to file for the EU, the company said it expects to have 20 million doses by the end of 2020 and 1 billion doses globally by 2021. The shot, which is a two-dose pocket, will be ready to ship in a week, according to the company.
Pfizer has already applied to the EU and the FDA plans to make a decision in early December. AstraZeneca has also indicated that it is preparing to file for its own EUA.
Quick facts
- Moderna to submit coronavirus vaccine for emergency use authorization
- The company plans to have 20 million doses ready by the end of 2020
- The United States has surpassed 13.3 million cases of the virus
Since the outbreak began, U.S. Has reached more than 13.3 million confirmed cases of the virus, according to Johns Hopkins University.
Follow below for the latest updates about the coronavirus epidemic. Mobile users click here.
